These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Theoretical considerations regarding the early use of adjuvant chemotherapy. Goldie JH; Coldman AJ Recent Results Cancer Res; 1986; 103():30-5. PubMed ID: 3738195 [No Abstract] [Full Text] [Related]
3. [Present and future of research in the diagnosis and treatment of cancer]. Escudero Barrilero A Arch Esp Urol; 1990 Jun; 43(5):463-78. PubMed ID: 2202263 [No Abstract] [Full Text] [Related]
4. Multiple drug resistance in cancer therapy. Schneider E; Cowan KH Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772 [No Abstract] [Full Text] [Related]
6. Concepts for the treatment of tumor metastasis. Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515 [No Abstract] [Full Text] [Related]
7. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential]. Larsson R; Nygren P; Bergh J Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991 [No Abstract] [Full Text] [Related]
9. The multidrug resistance phenotype in human cancer. Cordon-Cardo C; O'Brien JP Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363 [No Abstract] [Full Text] [Related]
10. [Glycoprotein in multidrug-resistant malignancies--clinical implications]. Ellis A; Lishner M; Manor J; Ravid M Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806 [No Abstract] [Full Text] [Related]
11. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field]. González-Manzano R Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549 [No Abstract] [Full Text] [Related]
12. Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer. DeMichele A; Yee D; Esserman L N Engl J Med; 2017 Dec; 377(23):2287-2289. PubMed ID: 29211674 [No Abstract] [Full Text] [Related]
13. Adjuvant and neoadjuvant therapy for gastric cancer. Gonzalez RJ; Mansfield PF Surg Clin North Am; 2005 Oct; 85(5):1033-51, viii. PubMed ID: 16139035 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of tumoral resistance to antineoplastic agents]. Albiero AL; Pozzi DH Rev Assoc Med Bras (1992); 1994; 40(2):125-8. PubMed ID: 7820150 [No Abstract] [Full Text] [Related]
17. Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents. Milas L; Tofilon PJ; Brock WA Prog Clin Biol Res; 1986; 212():305-21. PubMed ID: 3520579 [No Abstract] [Full Text] [Related]
18. Cancer therapeutics: personal experiences and future perspectives. Mihich E Cancer Biol Ther; 2004 Sep; 3(9):911-5. PubMed ID: 15326391 [No Abstract] [Full Text] [Related]
19. [Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs]. Possinger K; Hartenstein R; Ehrhart H MMW Munch Med Wochenschr; 1978 May; 120(21):725-8. PubMed ID: 306551 [No Abstract] [Full Text] [Related]
20. Thoughts on cancer chemotherapy and combination modality therapy (1974). Skipper HE JAMA; 1974 Nov; 230(7):1033-5. PubMed ID: 4608173 [No Abstract] [Full Text] [Related] [Next] [New Search]